New! Sign up for our free email newsletter.
Science News
from research organizations

Cancer research: Molecular machinery critical for cell's ability to move identified

Date:
December 17, 2019
Source:
University of Helsinki
Summary:
Two specific proteins take apart the cell's actin filaments at one end and return the building blocks to the other end for a new round of polymerization. The structure of this machinery driving cell motility may open new opportunities for developing therapeutics to inhibit cell migration in cancer.
Share:
FULL STORY

Many cells in our body constantly change their shape and move within our tissues. For example, wound healing and the immune system depend on migrating cells. On the other hand, uncontrolled cell migration is a hallmark of metastasis during the development of malignant cancers, so cell migration must be very tightly regulated.

The driving force for cell migration is produced by a protein called actin. Actin monomers act as building blocks by polymerising into rod-like filaments that push the leading edge of the cell forward. The polymerisation of the actin filaments must be balanced by depolymerisation of the filaments at the other end.

Now, scientists at the University of Helsinki, Finland, and Institut Jacques Monod, France, have identified a molecular machinery which drives rapid depolymerisation of actin filaments and recycles the resulting actin monomers for a new round of polymerisation. Two proteins, cyclase-associated protein and cofilin, work together in this.

"By using X-ray crystallography and computer simulations, we could actually see the atomic details of how these two proteins embrace actin filaments and disassemble them into their building blocks. One of the most exciting parts of the project was to see under the microscope how actin filaments suddenly began disappearing when we introduced these two proteins into their vicinity," says PhD student Tommi Kotila, the lead author of the study.

In malignant tumours, cells go haywire in their movements, because their migration machinery is not properly controlled. Because, in cancer cells, the regulation of cyclase-associated protein is often defective, the atomistic structure of this machinery may open new avenues for developing therapeutics to inhibit cell migration in cancer.

"This is a great contribution to our understanding of the basic principles of cell migration. It also helps us understand the molecular basis of the uncontrolled migration of cancer cells," says academy professor Pekka Lappalainen.


Story Source:

Materials provided by University of Helsinki. Note: Content may be edited for style and length.


Journal Reference:

  1. Tommi Kotila, Hugo Wioland, Giray Enkavi, Konstantin Kogan, Ilpo Vattulainen, Antoine Jégou, Guillaume Romet-Lemonne, Pekka Lappalainen. Mechanism of synergistic actin filament pointed end depolymerization by cyclase-associated protein and cofilin. Nature Communications, 2019; 10 (1) DOI: 10.1038/s41467-019-13213-2

Cite This Page:

University of Helsinki. "Cancer research: Molecular machinery critical for cell's ability to move identified." ScienceDaily. ScienceDaily, 17 December 2019. <www.sciencedaily.com/releases/2019/12/191217110155.htm>.
University of Helsinki. (2019, December 17). Cancer research: Molecular machinery critical for cell's ability to move identified. ScienceDaily. Retrieved May 23, 2024 from www.sciencedaily.com/releases/2019/12/191217110155.htm
University of Helsinki. "Cancer research: Molecular machinery critical for cell's ability to move identified." ScienceDaily. www.sciencedaily.com/releases/2019/12/191217110155.htm (accessed May 23, 2024).

Explore More

from ScienceDaily

RELATED STORIES